Instem plc
("Instem")
Posting of Annual Report and Accounts
Notice of Annual General Meeting
Instem plc (AIM: INS.L), a leading provider of IT solutions to the global early development healthcare market, has posted its Annual Report and Accounts for the year ended 31 December 2014 to shareholders, together with the Notice of the Annual General Meeting to be held at 12.00 noon on Tuesday 19 May 2015, at the offices of Baker Tilly, 3 Hardman Street, Manchester M3 3HF.
A copy of the Annual Report and Accounts is available on Instem's website at: http://investors.instem.com.
For further information, please contact:
Instem plc |
Tel: +44 (0) 1785 825 600 |
Phil Reason, CEO |
www.instem.com |
Nigel Goldsmith, CFO |
|
|
|
N+1 Singer (Nominated Adviser & Broker) |
Tel: +44 (0) 20 7496 3000 |
Richard Lindley |
|
Nick Owen |
|
|
|
Walbrook PR Ltd |
Tel: +44 (0) 20 7933 8780 or |
Paul Cornelius |
instem@walbrookpr.com |
Sam Allen |
|
Helen Cresswell |
|
About Instem
Instem is a leading supplier of IT applications to the early development healthcare market, delivering compelling solutions for data collection, management and analysis across the R&D continuum. Instem applications are in use by customers worldwide, meeting the rapidly expanding needs of life science and healthcare organizations for data-driven decision making leading to safer, more effective products.
Instem's portfolio of software solutions increases client productivity by automating study-related processes while offering the unique ability to generate new knowledge through the extraction and harmonization of actionable scientific information.
Instem supports over 400 clients through full service offices in the United States, United Kingdom and China with an additional location in India and a full service distributor based in Japan.
To learn more about Instem solutions and its mission, please visit www.instem.com